NEW YORK (GenomeWeb) – Hologic reported after the close of the market Wednesday that revenues for its first quarter of fiscal year 2019 were up 5 percent year over year, driven by strength in its US breast health, global molecular diagnostics, and international businesses.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.